js111
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 13, 2021 (NCT04993391)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
EGFR inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06940401 | Phase 1/Phase 2 (Phase 2) | Apr 30, 2025 | Shanghai Junshi Bioscience Co.,Ltd., Sponsor GmbH |
| NCT04993391 | Phase 1/Phase 2 (Phase 2) | Jul 13, 2021 | Shanghai Junshi Bioscience Co.,Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shanghai Junshi Bioscience Co.,Ltd. | For profit | 2 | 2 | 1 | 2021 |
| Sponsor GmbH | Academic/Hospital | 1 | 0 | 1 | 2025 |
2 organizations
Page 1 / 1